a public good project by the
Synthesis
Company
of California

© 2026

Emmanuel de Maistre | doi.page

0 works0 citations0 h-index

Emmanuel de Maistre

Centre Hospitalier Universitaire Dijon Bourgogne(FR)Maison des Sciences sociales et des Humanités de Dijon(FR)

Publications by Year

Research Areas

Venous Thromboembolism Diagnosis and Management, Heparin-Induced Thrombocytopenia and Thrombosis, Platelet Disorders and Treatments, Atrial Fibrillation Management and Outcomes, Intramuscular injections and effects

Most-Cited Works

→ Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy(2016)307 cited
→ Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013(2013)305 cited
→ Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis(1997)284 cited
→ Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus(2011)172 cited
→ Natural history of patients with congenital dysfibrinogenemia(2014)169 cited

→ Bleeding risk of surgery and its prevention in patients with inherited platelet disorders(2017)

125 cited

→ Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature(2017)123 cited

→ Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia(2021)114 cited

→ Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin(2006)105 cited

Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.(2007)